Gene Symbol | NXPE2 |
---|---|
Entrez Gene | 120406 |
Alt Symbol | FAM55B |
Species | Human |
Gene Type | protein-coding |
Description | neurexophilin and PC-esterase domain family, member 2 |
Other Description | NXPE family member 2|family with sequence similarity 55, member B|protein FAM55B |
Swissprots | Q2NKI8 Q96DL1 |
Accessions | EAW67255 Q96DL1 AK057953 BAB71621 BC111797 BC148385 AAI48386 BC156724 AAI56725 XM_011542604 XP_011540906 XM_011542605 XP_011540907 NM_182495 NP_872301 |
Subcellular Location | Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. |
FAM55B CRISPR/Cas9 KO Plasmid (h) - sc-414154 from Santa Cruz Biotechnology
|
||||||||
FAM55B HDR Plasmid (h) - sc-414154-HDR from Santa Cruz Biotechnology
|
||||||||
FAM55B Double Nickase Plasmid (h) - sc-414154-NIC from Santa Cruz Biotechnology
|
||||||||
FAM55B Double Nickase Plasmid (h2) - sc-414154-NIC-2 from Santa Cruz Biotechnology
|
||||||||
FAM55B CRISPR Activation Plasmid (h) - sc-414154-ACT from Santa Cruz Biotechnology
|
||||||||
FAM55B CRISPR Activation Plasmid (h2) - sc-414154-ACT-2 from Santa Cruz Biotechnology
|
||||||||
FAM55B Lentiviral Activation Particles (h) - sc-414154-LAC from Santa Cruz Biotechnology
|
||||||||
FAM55B Lentiviral Activation Particles (h2) - sc-414154-LAC-2 from Santa Cruz Biotechnology
|
||||||||
FAM55B siRNA (h) - sc-96266 from Santa Cruz Biotechnology
|
||||||||
FAM55B shRNA Plasmid (h) - sc-96266-SH from Santa Cruz Biotechnology
|
||||||||
FAM55B shRNA (h) Lentiviral Particles - sc-96266-V from Santa Cruz Biotechnology
|
||||||||
MISSION® esiRNA - EHU118311 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit - CKOZFN8357 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit, ZFN plasmid only - CKOZFND8357 from Sigma-Aldrich
|
||||||||
NXPE2 siRNA (Human) - CRJ4642 from Cohesion Biosciences
|
||||||||
Human NXPE2 siRNA - orb275143 from Biorbyt
|
||||||||
NXPE2 shRNA Plasmid (Human) - CHJ4642 from Cohesion Biosciences
|
||||||||
NXPE2 miRNA 3'UTR clone - MiUTR4H-TG03281 from Creative biogene
|
||||||||